Anna Spreafico

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 48

Top Topics

Monoclonal Antibody

Squamous Cell Carcinoma

Top Venues

British journal of cancer

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer discovery 14 (6) (2024)
Helen J Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Paulino Tallón de Lara, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan D Curti, Nikhil I Khushalani, Matthew H Taylor, Gregory A Daniels, Anna Spreafico, Tarek Meniawy, Alfons J M Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V Long, Celeste Lebbè
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology 8 (1) (2024)
Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer discovery 14 (6) (2024)
Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger, Andrea Viviana Pastor, Erin R Alesi, Anterpreet Neki, Andrea S Fung, Iane Pinto Figueiredo Lima, Peter Oppelt, Geraldo Felicio da Cunha Junior, Barbara A Burtness, Fabio Andre Franke, Jennifer E Tseng, Abhishek Joshi, Joy McCarthy, Ramona Swaby, Yulia Sidi, Burak Gumuscu, Niroshini Naicker, Gilberto de Castro Junior
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger, Andrea Viviana Pastor, Erin R Alesi, Anterpreet Neki, Andrea S Fung, Iane Pinto Figueiredo Lima, Peter Oppelt, Geraldo Felicio da Cunha Junior, Barbara A Burtness, Fabio Andre Franke, Jennifer E Tseng, Abhishek Joshi, Joy McCarthy, Ramona Swaby, Yulia Sidi, Burak Gumuscu, Niroshini Naicker, Gilberto de Castro Junior
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Marc Oliva, Alya Heirali, Geoffrey Watson, Ashley M Rooney, Kyla Cochrane, Sarah Jennings, Rachel Taylor, Minge Xu, Ali Hosni, Andrew Hope, Scott V Bratman, Douglas Chepeha, Ilan Weinreb, Bayardo Perez-Ordonez, Ricard Mesia Nin, John Waldron, Wei Xu, Aaron R Hansen, Lillian L Siu, Bryan Coburn, Anna Spreafico
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study. British journal of cancer 130 (12) (2024)
Marc Oliva, Alya Heirali, Geoffrey Watson, Ashley M Rooney, Kyla Cochrane, Sarah Jennings, Rachel Taylor, Minge Xu, Ali Hosni, Andrew Hope, Scott V Bratman, Douglas Chepeha, Ilan Weinreb, Bayardo Perez-Ordonez, Ricard Mesia Nin, John Waldron, Wei Xu, Aaron R Hansen, Lillian L Siu, Bryan Coburn, Anna Spreafico
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study. British journal of cancer 130 (12) (2024)
Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer discovery 14 (6) (2024)
Helen J Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Paulino Tallón de Lara, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan D Curti, Nikhil I Khushalani, Matthew H Taylor, Gregory A Daniels, Anna Spreafico, Tarek Meniawy, Alfons J M Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V Long, Celeste Lebbè
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology 8 (1) (2024)
Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger, Andrea Viviana Pastor, Erin R Alesi, Anterpreet Neki, Andrea S Fung, Iane Pinto Figueiredo Lima, Peter Oppelt, Geraldo Felicio da Cunha Junior, Barbara A Burtness, Fabio Andre Franke, Jennifer E Tseng, Abhishek Joshi, Joy McCarthy, Ramona Swaby, Yulia Sidi, Burak Gumuscu, Niroshini Naicker, Gilberto de Castro Junior
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger, Andrea Viviana Pastor, Erin R Alesi, Anterpreet Neki, Andrea S Fung, Iane Pinto Figueiredo Lima, Peter Oppelt, Geraldo Felicio da Cunha Junior, Barbara A Burtness, Fabio Andre Franke, Jennifer E Tseng, Abhishek Joshi, Joy McCarthy, Ramona Swaby, Yulia Sidi, Burak Gumuscu, Niroshini Naicker, Gilberto de Castro Junior
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Abhinav Thakral, John J W Lee, Tianzhichao Hou, Katrina Hueniken, Tom Dudding, Mark Gormley, Shama Virani, Andrew Olshan, Brenda Diergaarde, Andrew R Ness, Tim Waterboer, Karl Smith Byrne, Paul Brennan, David Neil Hayes, Eleanor C M Sanderson, M Catherine Brown, Sophie Huang, Scott V Bratman, Anna Spreafico, John De Almeida, Joel C Davies, Laura J Bierut, Gary J Macfarlane, Pagona Lagiou, Areti Lagiou, Jerry Polesel, Antonio Agudo, Laia Alemany, Wolfgang Ahrens, Claire M Healy, David I Conway, Mari Nygard, Cristina Canova, Ivana Holcatova, Lorenzo Richiardi, Ariana Znaor, David Paul Goldstein, Rayjean J Hung, Wei Xu, Geoffrey Liu, Osvaldo Espin-Garcia
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nature communications 15 (1) (2024)
Scott C Lien, Dalam Ly, S Y Cindy Yang, Ben X Wang, Derek L Clouthier, Michael St Paul, Ramy Gadalla, Babak Noamani, Carlos R Garcia-Batres, Sarah Boross-Harmer, Philippe L Bedard, Trevor J Pugh, Anna Spreafico, Naoto Hirano, Albiruni R A Razak, Pamela S Ohashi
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient. Nature communications 15 (1) (2024)
Marc Oliva, Alya Heirali, Geoffrey Watson, Ashley M Rooney, Kyla Cochrane, Sarah Jennings, Rachel Taylor, Minge Xu, Ali Hosni, Andrew Hope, Scott V Bratman, Douglas Chepeha, Ilan Weinreb, Bayardo Perez-Ordonez, Ricard Mesia Nin, John Waldron, Wei Xu, Aaron R Hansen, Lillian L Siu, Bryan Coburn, Anna Spreafico
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study. British journal of cancer (2024)
Scott C Lien, Dalam Ly, S Y Cindy Yang, Ben X Wang, Derek L Clouthier, Michael St Paul, Ramy Gadalla, Babak Noamani, Carlos R Garcia-Batres, Sarah Boross-Harmer, Philippe L Bedard, Trevor J Pugh, Anna Spreafico, Naoto Hirano, Albiruni R A Razak, Pamela S Ohashi
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient. Nature communications 15 (1) (2024)
Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early changes in tumor-naive cell-free methylomes and fragmentomes predict outcomes in pembrolizumab-treated solid tumors. Cancer discovery (2024)
Marc Oliva, Alya Heirali, Geoffrey Watson, Ashley M Rooney, Kyla Cochrane, Sarah Jennings, Rachel Taylor, Minge Xu, Ali Hosni, Andrew Hope, Scott V Bratman, Douglas Chepeha, Ilan Weinreb, Bayardo Perez-Ordonez, Ricard Mesia Nin, John Waldron, Wei Xu, Aaron R Hansen, Lillian L Siu, Bryan Coburn, Anna Spreafico
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study. British journal of cancer 130 (12) (2024)
Suzanne Kazandjian, Emmanuelle Rousselle, Matthew Dankner, David W Cescon, Anna Spreafico, Kim Ma, Petr Kavan, Gerald Batist, April A N Rose
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers. Cancers 16 (2) (2024)
Helen J Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Paulino Tallón de Lara, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan D Curti, Nikhil I Khushalani, Matthew H Taylor, Gregory A Daniels, Anna Spreafico, Tarek Meniawy, Alfons J M Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V Long, Celeste Lebbè
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology 8 (1) (2024)
Suzanne Kazandjian, Emmanuelle Rousselle, Matthew Dankner, David W Cescon, Anna Spreafico, Kim Ma, Petr Kavan, Gerald Batist, April A N Rose
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers. Cancers 16 (2) (2024)
Scott C Lien, Dalam Ly, S Y Cindy Yang, Ben X Wang, Derek L Clouthier, Michael St Paul, Ramy Gadalla, Babak Noamani, Carlos R Garcia-Batres, Sarah Boross-Harmer, Philippe L Bedard, Trevor J Pugh, Anna Spreafico, Naoto Hirano, Albiruni R A Razak, Pamela S Ohashi
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient. Nature communications 15 (1) (2024)
Erica C Koch Hein, Maysa Vilbert, Ian Hirsch, Maurício Fernando Silva Almeida Ribeiro, Thiago P Muniz, Cynthia Fournier, Khaled Abdulalem, Erick Figueiredo Saldanha, Erika Martinez, Anna Spreafico, David H Hogg, Marcus O Butler, Samuel D Saibil
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre. Cancers 15 (17) (2023)
Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, Todd M Bauer, Aaron R Hansen, Daniel C Cho, F Stephen Hodi, Jan H M Schellens, Jennifer K Litton, Sandrine Aspeslagh, Karen A Autio, Frans L Opdam, Meredith McKean, Neeta Somaiah, Stephane Champiat, Mehmet Altan, Anna Spreafico, Osama Rahma, Elaine M Paul, Christoph M Ahlers, Helen Zhou, Herbert Struemper, Shelby A Gorman, Maura Watmuff, Kaitlin M Yablonski, Niranjan Yanamandra, Michael J Chisamore, Emmett V Schmidt, Axel Hoos, Aurélien Marabelle, Jeffrey S Weber, John V Heymach
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Journal for immunotherapy of cancer 11 (3) (2023)
Pavlina Spiliopoulou, Olga Vornicova, Sofia Genta, Anna Spreafico
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers. International journal of molecular sciences 24 (2) (2023)
Abdulazeez Salawu, Ben X Wang, Ming Han, Caryn Geady, Alya Heirali, Hal K Berman, Thomas D Pfister, Alberto Hernando-Calvo, Esmail Mutahar Al-Ezzi, Lee-Anne Stayner, Abha A Gupta, Olubukola Ayodele, Bernard Lam, Aaron Richard Hansen, Anna Spreafico, Philippe L Bedard, Marcus O Butler, Lisa Avery, Bryan Coburn, Benjamin Haibe-Kains, Lillian L Siu, Albiruni Abdul Razak
Safety, immunologic and clinical activity of Durvalumab in combination with Olaparib or Cediranib in advanced leiomyosarcoma: Results of the DAPPER clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Pavlina Spiliopoulou, Carlos Diego Holanda Lopes, Anna Spreafico
Promising and Minimally Invasive Biomarkers: Targeting Melanoma. Cells 13 (1) (2023)
Pavlina Spiliopoulou, Olga Vornicova, Sofia Genta, Anna Spreafico
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers. International journal of molecular sciences 24 (2) (2023)
Todd M Bauer, Armando Santoro, Chia-Chi Lin, Ignacio Garrido-Laguna, Markus Joerger, Richard Greil, Anna Spreafico, Thomas Yau, Maria-Elisabeth Goebeler, Marie Luise Hütter-Krönke, Antonella Perotti, Pierre-Eric Juif, Darlene Lu, Louise Barys, Viviana Cremasco, Marc Pelletier, Helen Evans, Claire Fabre, Toshikiko Doi
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors. Journal for immunotherapy of cancer 11 (11) (2023)
Pavlina Spiliopoulou, Carlos Diego Holanda Lopes, Anna Spreafico
Promising and Minimally Invasive Biomarkers: Targeting Melanoma. Cells 13 (1) (2023)
Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, Todd M Bauer, Aaron R Hansen, Daniel C Cho, F Stephen Hodi, Jan H M Schellens, Jennifer K Litton, Sandrine Aspeslagh, Karen A Autio, Frans L Opdam, Meredith McKean, Neeta Somaiah, Stephane Champiat, Mehmet Altan, Anna Spreafico, Osama Rahma, Elaine M Paul, Christoph M Ahlers, Helen Zhou, Herbert Struemper, Shelby A Gorman, Maura Watmuff, Kaitlin M Yablonski, Niranjan Yanamandra, Michael J Chisamore, Emmett V Schmidt, Axel Hoos, Aurélien Marabelle, Jeffrey S Weber, John V Heymach
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Journal for immunotherapy of cancer 11 (3) (2023)
Maysa Vilbert, Erica C Koch, April A N Rose, Rob C Laister, Diana Gray, Valentin Sotov, Susanne Penny, Anna Spreafico, Devanand M Pinto, Marcus O Butler, Samuel D Saibil
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy. Cancers 15 (14) (2023)
Seth Kibel, Nathan Kuehne, Maurício Fernando Silva Almeida Ribeiro, Thiago P Muniz, Xiang Y Ye, Anna Spreafico, Samuel D Saibil, Alexander Sun, David Y Mak, Diana Gray, Bailie Jones, Philip Wong, Marcus O Butler
The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies. Cancers 15 (24) (2023)
Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, Todd M Bauer, Aaron R Hansen, Daniel C Cho, F Stephen Hodi, Jan H M Schellens, Jennifer K Litton, Sandrine Aspeslagh, Karen A Autio, Frans L Opdam, Meredith McKean, Neeta Somaiah, Stephane Champiat, Mehmet Altan, Anna Spreafico, Osama Rahma, Elaine M Paul, Christoph M Ahlers, Helen Zhou, Herbert Struemper, Shelby A Gorman, Maura Watmuff, Kaitlin M Yablonski, Niranjan Yanamandra, Michael J Chisamore, Emmett V Schmidt, Axel Hoos, Aurélien Marabelle, Jeffrey S Weber, John V Heymach
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Journal for immunotherapy of cancer 11 (3) (2023)
Pavlina Spiliopoulou, Carlos Diego Holanda Lopes, Anna Spreafico
Promising and Minimally Invasive Biomarkers: Targeting Melanoma. Cells 13 (1) (2023)
Helena J Janse van Rensburg, Zhihui Liu, Geoffrey Alan Watson, Zachary W Veitch, Daniel Shepshelovich, Anna Spreafico, Albiruni R Abdul Razak, Philippe L Bedard, Lillian L Siu, Lori Minasian, Aaron Richard Hansen
A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events. British journal of cancer (2023)
Maria Vieito, Victor Moreno, Anna Spreafico, Irene Brana, Judy S Wang, Meir Preis, Tatiana Hernández, Sofia Genta, Aaron Richard Hansen, Bernard Doger, Vladimir Galvao, Laurie Lenox, Regina J Brown, Anna Kalota, Jaydeep Mehta, Friederike Pastore, Bharvin Patel, Pankaj Mistry, Junchen Gu, Josh D Lauring, Manish R Patel
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Pavlina Spiliopoulou, Olga Vornicova, Sofia Genta, Anna Spreafico
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers. International journal of molecular sciences 24 (2) (2023)
Pavlina Spiliopoulou, Carlos Diego Holanda Lopes, Anna Spreafico
Promising and Minimally Invasive Biomarkers: Targeting Melanoma. Cells 13 (1) (2023)
Seth Kibel, Nathan Kuehne, Maurício Fernando Silva Almeida Ribeiro, Thiago P Muniz, Xiang Y Ye, Anna Spreafico, Samuel D Saibil, Alexander Sun, David Y Mak, Diana Gray, Bailie Jones, Philip Wong, Marcus O Butler
The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies. Cancers 15 (24) (2023)
Funda Meric-Bernstam, Randy F Sweis, Stefan Kasper, Omid Hamid, Shailender Bhatia, Reinhard Dummer, Agostina Stradella, Georgina V Long, Anna Spreafico, Toshio Shimizu, Neeltje Steeghs, Jason John Luke, Sarah M McWhirter, Thomas Müller, Nitya Nair, Nancy Lewis, Xinhui Chen, Andrew Bean, Lisa M Kattenhorn, Marc R Pelletier, Shahneen Sandhu
Combination of the STING Agonist MIW815 and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-label, Multicenter, Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Marc Oliva, Douglas Chepeha, Daniel Vilarim Araújo, J Javier Diaz-Mejia, Peter Olson, Amy Prawira, Anna Spreafico, Scott V Bratman, Tina Shek, John de Almeida, Aaron R Hansen, Andrew Hope, David Goldstein, Ilan Weinreb, Stephen Smith, Bayardo Perez-Ordoñez, Jonathan Irish, Dax Torti, Jeffrey P Bruce, Ben X Wang, Anthony Fortuna, Trevor J Pugh, Hirak Der-Torossian, Ronald Shazer, Nickolas Attanasio, Qingyan Au, Antony Tin, Jordan Feeney, Himanshu Sethi, Alexey Aleshin, Isan Chen, Lillian L Siu
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study. Journal for immunotherapy of cancer 9 (10) (2022)
Geoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, Zhihui Amy Liu, Sy Cindy Yang, Ben Wang, Shaofeng Liu, Shawn Kubli, Hal Berman, Thomas Pfister, Sofia Genta, Anna Spreafico, Aaron R Hansen, Philippe L Bedard, Stéphanie Lheureux, Albiruni Abdul Razak, Dave Cescon, Marcus O Butler, Wei Xu, Tak W Mak, Lillian L Siu, Eric X Chen
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab. Journal for immunotherapy of cancer 10 (6) (2022)
Geoffrey Alan Watson, Zachary W Veitch, Daniel Shepshelovich, Zhihui Amy Liu, Anna Spreafico, Albiruni R Abdul Razak, Philippe L Bedard, Lillian L Siu, Lori Minasian, Aaron Richard Hansen
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE. British journal of cancer 127 (9) (2022)
Zachary W Veitch, Daniel Shepshelovich, Christina Gallagher, Lisa Wang, Albiruni R Abdul Razak, Anna Spreafico, Philippe L Bedard, Lillian L Siu, Lori M Minasian, Aaron Richard Hansen
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials. Journal of the National Cancer Institute 113 (8) (2022)
April A N Rose, Susan M Armstrong, David Hogg, Marcus O Butler, Samuel D Saibil, Diana P Arteaga, Thiago Pimentel Muniz, Deirdre Kelly, Danny Ghazarian, Ian King, Zaid Saeed Kamil, Kendra Ross, Anna Spreafico
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy. Journal for immunotherapy of cancer 9 (1) (2021)
Marc Oliva, Pierre H H Schneeberger, Victor Rey, Matthew Cho, Rachel Taylor, Aaron R Hansen, Kirsty Taylor, Ali Hosni, Andrew Bayley, Andrew J Hope, Scott V Bratman, Jolie Ringash, Simron Singh, Ilan Weinreb, Bayardo Perez-Ordoñez, Douglas Chepeha, John Waldron, Wei Xu, David Guttman, Lillian L Siu, Bryan Coburn, Anna Spreafico
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study). British journal of cancer 124 (9) (2021)
Geoffrey Alan Watson, Jeffrey Doi, Aaron Richard Hansen, Anna Spreafico
Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift? British journal of clinical pharmacology 86 (9) (2020)
Tira Jing Ying Tan, Michael Rheaume, Lisa Wang, Helen Chow, Anna Spreafico, Aaron Richard Hansen, Albiruni Abdul Razak, Lillian L Siu, Philippe L Bedard
Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era. The oncologist 24 (7) (2019)